Feature Channels: Vaccines

Filters close
Newswise: Anti-vaccine conspiracies fuel divisive political discourse
Released: 26-Feb-2024 9:05 PM EST
Anti-vaccine conspiracies fuel divisive political discourse
University of Tokyo

Heightened use of social media during the coronavirus pandemic brought with it an unprecedented surge in the spread of misinformation.

   
Newswise:Video Embedded measles-makes-a-comeback-what-parents-need-to-know
VIDEO
Released: 23-Feb-2024 2:05 PM EST
Measles Makes a Comeback: What Parents Need to Know
Cedars-Sinai

A highly contagious childhood disease once eradicated by vaccination has made a comeback.

Newswise: Off-the-shelf vaccine offers hope for pancreatic and colorectal cancer patients with KRAS mutations
Released: 23-Feb-2024 10:05 AM EST
Off-the-shelf vaccine offers hope for pancreatic and colorectal cancer patients with KRAS mutations
University of California, Los Angeles (UCLA), Health Sciences

Samara Rahman, 74, enrolled in a clinical trial at UCLA Health that was evaluating an “off-the-shelf” vaccine that is given after surgery to prevent or delay the cancer from coming back in high-risk patients.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 2:05 AM EST
Researchers are using RNA in a new approach to fight HIV
University of Waterloo

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.

Released: 19-Feb-2024 8:05 PM EST
Studies find flu vaccines were effective in 2022-2023 flu season
Regenstrief Institute

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

Newswise: Covid vaccine for pregnant women safe for newborn infants
Released: 7-Feb-2024 1:05 AM EST
Covid vaccine for pregnant women safe for newborn infants
Karolinska Institute

No increased risks for babies, and for some serious neonatal complications lower risks.

Released: 6-Feb-2024 6:05 PM EST
Trust in doctors, not public officials, boosts COVID-19 vaccination
New York University

While this expression has become an advertising slogan and meme, physicians and nurses continually rank among the most trusted professions in the U.S.

Newswise: How T cells combat tuberculosis
Released: 6-Feb-2024 11:05 AM EST
How T cells combat tuberculosis
La Jolla Institute for Immunology

Scientists at La Jolla Institute for Immunology (LJI) have uncovered important clues to how human T cells combat the bacterium that causes tuberculosis.

Released: 1-Feb-2024 12:05 PM EST
American Society of Anesthesiologists welcomes improvements to No Surprises Act IDR process
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) commends the Centers for Medicare & Medicaid Services (CMS) for taking positive steps towards returning balance to the independent dispute resolution (IDR) process of the No Surprises Act (NSA) through a recently proposed rule.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Released: 30-Jan-2024 1:05 PM EST
DNA particles that mimic viruses hold promise as vaccines
Massachusetts Institute of Technology (MIT)

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

Newswise: Soap bark discovery offers a sustainability booster for the global vaccine market
Released: 26-Jan-2024 10:05 AM EST
Soap bark discovery offers a sustainability booster for the global vaccine market
John Innes Centre

A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.

   
Newswise: Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
24-Jan-2024 4:05 PM EST
Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children
University of Maryland School of Medicine

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

Newswise:Video Embedded beyond-bmi-ohio-state-expert-says-complete-approach-to-measuring-health-is-better
VIDEO
Released: 23-Jan-2024 12:00 PM EST
Beyond BMI, Ohio State expert says complete approach to measuring health is better
Ohio State University Wexner Medical Center

For decades, the number on a scale has been a key factor in deciding whether a person is healthy or not. But weight alone doesn’t paint a complete picture of one’s health.

Released: 22-Jan-2024 11:05 AM EST
American Society of Anesthesiologists (ASA) Welcomes Vince Loffredo, Ed.D., as Chief Learning Officer
American Society of Anesthesiologists (ASA)

In a strategic move, ASA has hired Vince Loffredo, Ed.D., as its new Chief Learning Officer, where he will oversee the Education, Meetings, and Publications departments, as well as serve as a vital member of ASA’s CEO team.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Newswise: Remodeling the immune system to fight tuberculosis
Released: 19-Jan-2024 7:05 AM EST
Remodeling the immune system to fight tuberculosis
University of Massachusetts Amherst

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide—and that number is only growing larger.

Newswise: We Need a Staph Vaccine: Here’s Why We Don’t Have One
11-Jan-2024 11:00 AM EST
We Need a Staph Vaccine: Here’s Why We Don’t Have One
University of California San Diego

A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.

Released: 16-Jan-2024 7:05 AM EST
A call for improved CDC communication on adult immunization
CUNY Graduate School of Public Health and Health Policy

In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to “raise its persuasive communications game” on adult immunization to clinicians and the public.

Newswise: Studies examine different responses to SARS-CoV-2 variants
Released: 12-Jan-2024 12:05 PM EST
Studies examine different responses to SARS-CoV-2 variants
UT Southwestern Medical Center

Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.

Not for public release

This news release is embargoed until 11-Jan-2024 1:00 PM EST Released to reporters: 4-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Jan-2024 1:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Released: 11-Jan-2024 10:05 AM EST
Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Cedars-Sinai

Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and insurance status.

Released: 11-Jan-2024 8:50 AM EST
mRNA technology could be possible treatment for rare diseases
University College London

The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.

Released: 10-Jan-2024 10:20 AM EST
Hackensack Meridian Center for Discovery and Innovation Welcomes New Board Member, Dr. Daria Hazuda
Hackensack Meridian Health

Renowned scientist in vaccine and infectious disease research joins prestigious board of visionary leaders

Newswise: image.jpg
Released: 10-Jan-2024 10:05 AM EST
Winter spikes of the flu, COVID-19, and RSV; expert offers tips and advice for staying healthy
Virginia Tech

Federal officials are describing a ‘tripledemic’ of respiratory infections on the rise. Flu, COVID-19, and RSV are spiking, as expected, as we are in the mid-winter months. Lisa M. Lee, a professor of public health at Virginia Tech, answered questions about factors for concern and the importance of vaccination. Lee is an epidemiologist and bioethicist who has worked in public health and ethics for 25 years, including 14 years with CDC.

Released: 9-Jan-2024 2:05 PM EST
Sickle cell raises COVID-19 risk, but vaccination lags
Michigan Medicine - University of Michigan

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.

Newswise: Protecting newborns: Research lays the groundwork for a lifesaving vaccine
Released: 9-Jan-2024 9:05 AM EST
Protecting newborns: Research lays the groundwork for a lifesaving vaccine
Binghamton University, State University of New York

Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.

5-Jan-2024 5:05 PM EST
Vaccine demonstrates potential in delaying relapse of KRAS-mutated pancreatic and colorectal cancers
University of Texas MD Anderson Cancer Center

A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.

   

Not for public release

This news release is embargoed until 8-Jan-2024 5:00 PM EST Released to reporters: 2-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

5-Jan-2024 4:05 PM EST
Real-world analysis: COVID-19 vaccine strongly effective for children and adolescents during delta and omicron
Perelman School of Medicine at the University of Pennsylvania

In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase

Not for public release

This news release is embargoed until 8-Jan-2024 5:00 PM EST Released to reporters: 2-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jan-2024 11:05 AM EST
SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung
Ohio State University

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

Newswise:Video Embedded rise-of-the-tripledemic
VIDEO
Released: 5-Jan-2024 1:05 PM EST
Rise of the Tripledemic
Cedars-Sinai

As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
4-Jan-2024 10:10 AM EST
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
University of California, San Francisco (UCSF)

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

Newswise: New Study: Is There a Link Between COVID-19 Vaccination and POTS?
Released: 4-Jan-2024 12:05 AM EST
New Study: Is There a Link Between COVID-19 Vaccination and POTS?
Cedars-Sinai

A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.

Released: 3-Jan-2024 7:05 AM EST
RSV vaccines would greatly reduce illness if implemented like flu shots
Yale University

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

Released: 2-Jan-2024 4:05 PM EST
The ‘tripledemic’ surge
Michigan Medicine - University of Michigan

Study examines the impact of flu, RSV and COVID-19 hitting pediatric emergency departments

Released: 19-Dec-2023 11:05 AM EST
UNM Professor Develops Vaccine to Lower Cholesterol
University of New Mexico Comprehensive Cancer Center

Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC).

Newswise: Mineral coatings could enable shelf-stable mRNA therapies
Released: 15-Dec-2023 4:05 PM EST
Mineral coatings could enable shelf-stable mRNA therapies
University of Wisconsin–Madison

A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.In a new paper in the journal Acta Biomaterialia, Professor William Murphy and collaborators in his lab detail how using an optimized mineral coating composition can maintain mRNA activity for up to six months at room temperature.

12-Dec-2023 3:05 PM EST
‘Long flu’ has emerged as a consequence similar to long COVID
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.



close
1.46698